Sarasota Memorial Enrolls First Patient in Novel Clinical Trial for the Treatment of Papillary Thyroid Cancer
Business
SRQ DAILY MONDAY BUSINESS EDITION
MONDAY MAR 30, 2026 |
Sarasota Memorial is one of two research sites evaluating the effectiveness of a novel, minimally invasive treatment for papillary thyroid cancer. The study is led locally by Ralph P. Tufano, MD, MBA, FACS, thyroid and parathyroid surgeon with Sarasota Memorial’s Brian D. Jellison Cancer Institute, in collaboration with SMH’s Kolschowsky Research and Education Institute and principal investigator Victoria Banuchi, M.D., associate professor of Head & Neck Surgery at The University of Texas MD Anderson Cancer Center. A total of 30 patients will be enrolled across the two study sites. For information or to determine eligibility, contact the research team at (941) 917-2225 or researchinstitute@smh.com. For information about the national trial, visit: https://clinicaltrials.gov/study/NCT07218315
« View The Monday Mar 30, 2026 SRQ Daily Edition
« Back To SRQ Daily Archive
